Descriptor English: | Atorvastatin | ||||||
Descriptor Spanish: |
Atorvastatina
| ||||||
Descriptor Portuguese: | Atorvastatina | ||||||
Descriptor French: | Atorvastatine | ||||||
Entry term(s): |
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid Atorvastatin Calcium Atorvastatin Calcium Anhydrous Atorvastatin Calcium Hydrate Atorvastatin Calcium Trihydrate Atorvastatin, Calcium Salt CI 981 CI-981 CI981 Lipitor Liptonorm |
||||||
Tree number(s): |
D03.383.129.578.075 D10.251.450.200 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069059 | ||||||
Scope note: | A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anticholesteremic Agents Hydroxymethylglutaryl-CoA Reductase Inhibitors |
||||||
Registry Number: | A0JWA85V8F | ||||||
Public MeSH Note: | 2019; see ATORVASTATIN CALCIUM 2016-2018; ATORVASTATIN CALCIUM was indexed under HEPTANOIC ACIDS and PYRROLES 1990-2015 |
||||||
History Note: | 2019 (1990) |
||||||
DeCS ID: | 55918 | ||||||
Unique ID: | D000069059 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2016/01/01 | ||||||
Date of Entry: | 2015/07/10 | ||||||
Revision Date: | 2018/07/02 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Lipids [D10]Lipids
|
Atorvastatin
- Preferred
Atorvastatin Calcium
- Narrower
Liptonorm
- Narrower
Lipitor
- Narrower
Atorvastatin Calcium Hydrate
- Related but not broader or narrower
Atorvastatin Calcium Anhydrous
- Narrower
CI 981
- Narrower
Atorvastatin Calcium Trihydrate
- Narrower
Concept UI |
M0179294 |
Scope note | A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. |
Preferred term | Atorvastatin |
Entry term(s) |
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
Concept UI |
M0324841 |
Preferred term | Atorvastatin Calcium |
Entry term(s) |
Atorvastatin, Calcium Salt |
Concept UI |
M000604589 |
Preferred term | Liptonorm |
Concept UI |
M0179293 |
Preferred term | Lipitor |
Concept UI |
M000638387 |
Preferred term | Atorvastatin Calcium Hydrate |
Concept UI |
M0589476 |
Preferred term | Atorvastatin Calcium Anhydrous |
Concept UI |
M0179290 |
Preferred term | CI 981 |
Entry term(s) |
CI-981 CI981 |
Concept UI |
M000642807 |
Preferred term | Atorvastatin Calcium Trihydrate |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey